BLOG

Tuesday, October 30, 2018

Divis Labs earmarks Rs 15 bn for capex as greefield Kakinada project stalls

BS ReporterHyderabad, 29 October: Active pharmaceutical ingredients(APIs) and drug intermediates maker Divis Laboratories Limited is creating additional capacities by spending as much as Rs 15 billion at its existing facilities in the next 15 months to more than make up for the delayed green-field project plans in Kakinada.The company said it would be investing Rs 6 billion each at its Unit-2 of Vizag SEZ in Andhra Pradesh and Unit-1 of its Nalgonda SEZ in Telangana to build additional capacities besides spending another Rs 3 billion for debottlenecking of the Unit-2 in Vizag. The work of the ongoing capacity expansion is expected to be completed by the end of calendar year 2019.The company currently operates four multi-purpose manufacturing facilities out of these two sites. The management said the brown-field expansion was taken up in order to cater to the increasing opportunities in generic and big pharma business. The company is engaged in the manufacturing of key ingredients ...

from Companies https://ift.tt/2yzTCaQ
via IFTTT

No comments:

Post a Comment

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...